News

Business News Asia – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services

PERTH, W. AUSTRALIA — MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR’s share capital through the issue of 4 million PIQ shares.

This alliance will see Proteomics International applying its Promarker discovery platform to formulate a new series of predictive diagnostics and analytical services capabilities in compliment to CPR’s position as an APAC-based leader in the provision of clinical services and laboratory testing in clinical trials.

Article: Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services

Subscribe
  • This field is for validation purposes and should be left unchanged.